Sickle-cell thalassemia beta plus with crisis, unspecified is a genetic blood disorder characterized by the presence of both sickle cell disease and beta-thalassemia. This condition leads to abnormal hemoglobin production, resulting in hemolytic anemia, vaso-occlusive crises, and potential organ damage. Accurate coding with ICD-10 Code D57.459 is essential for proper diagnosis, documentation, medical billing, and public health reporting, ensuring that patients receive appropriate care and resources.
ICD-10 Code D57.459 represents Sickle-cell thalassemia beta plus with crisis, unspecified, a condition where patients experience complications from both sickle cell disease and beta-thalassemia. This code should be used when documenting cases of acute crises related to this condition, ensuring accurate representation of the patient's health status for clinical documentation and billing purposes.
Sickle-cell thalassemia beta plus with crisis, unspecified is caused by mutations in the HBB gene, leading to the production of abnormal hemoglobin. This condition can result in painful vaso-occlusive crises, increased risk of infections, and chronic complications affecting various organs. Prompt medical attention is necessary to manage symptoms and prevent serious complications.
ICD-10 Code D57.459 is utilized in SOAP notes to document the patient's symptoms, assessment findings, and treatment plans related to sickle-cell thalassemia beta plus with crisis. This code is relevant in both acute and chronic care settings, ensuring comprehensive documentation of the patient's condition and facilitating appropriate management.
In SOAP notes, ICD-10 Code D57.459 connects subjective reports of pain and other symptoms with objective clinical findings, leading to a formal diagnosis. This code supports continuity of care, aids in billing processes, and meets EHR documentation standards, ensuring that all aspects of the patient's condition are accurately captured.
Management of Sickle-cell thalassemia beta plus with crisis, unspecified often requires hospitalization due to the potential for severe complications. Treatment focuses on alleviating symptoms and preventing further crises.


HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn moreICD-10 Code D57.459 is crucial for billing in hospital, ER, or infectious disease care settings, ensuring accurate reimbursement for services rendered.
| CPT Code | Description |
|---|---|
| 36430 | Blood transfusion, per unit. |
| 96365 | IV infusion, for hydration or medication administration. |
| 99223 | Initial hospital care, typically requiring a detailed history and examination. |
Common Questions About Using ICD-10 Code D57.459 for Sickle-cell thalassemia beta plus with crisis, unspecified
What are the common symptoms of sickle-cell thalassemia beta plus?
Common symptoms include severe pain episodes, fatigue, pallor due to anemia, and increased susceptibility to infections. Patients may also experience complications such as acute chest syndrome.
How is sickle-cell thalassemia beta plus treated?
Treatment typically involves pain management, hydration, blood transfusions during crises, and prophylactic antibiotics to prevent infections. Regular monitoring and patient education are also crucial.
When should ICD-10 Code D57.459 be used?
This code should be used when documenting cases of sickle-cell thalassemia beta plus with acute crises, ensuring accurate representation of the patient's condition for billing and clinical documentation.
What is the importance of accurate coding for sickle-cell thalassemia beta plus?
Accurate coding is essential for proper diagnosis, treatment planning, reimbursement, and public health reporting. It ensures that patients receive appropriate care and resources.
Clinical Notes
SOAP notes
DAP notes
AI medical notes